BCL6 was initially identified as an oncogene in B-cell lymphomas, with this gene thought to drive the malignant phenotype by repressing proliferation and DNA damage checkpoints and blocking B-cell terminal differentiation (14). The gene discussed is BCL6; the disease is B-cell non-Hodgkin lymphoma.